Bulletin
Investor Alert

New York Markets After Hours

Sanofi ADR

NAS: SNY

GO
/marketstate/country/us

After Hours

SNY
/zigman2/quotes/201967021/composite

$

48.16

Change

0.00 0.00%

Volume

Volume 3,491

Feb 27, 2020, 4:41 p.m.

Real time quotes

/zigman2/quotes/201967021/composite

Today's close

$ 49.45

$ 48.16

Change

-1.29 -2.61%

Day low

Day high

$48.09

$49.14

Open
Open: 48.43

52 week low

52 week high

$40.00

$51.84

Open

Market cap

$123.94B

Average volume

1.69M

P/E ratio

29.50

Rev. per Employee

$390,092

EPS

1.63

Dividend

1.72

Div yield

2.40%

Ex dividend date

5/7/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sny

MarketWatch News on SNY

  1. Sanofi Plans Spinoff of Manufacturing Facilities

    12:25 p.m. Feb. 24, 2020

    - Josh Nathan-Kazis

  2. Sanofi says it's considering IPO of pharmaceutical-ingredients arm

    10:23 a.m. Feb. 24, 2020

    - Steve Goldstein

  3. Big Pharma Is Pushing Harder on a Vaccine

    9:29 a.m. Feb. 24, 2020

    - Josh Nathan-Kazis

  4. Sanofi to work on coronavirus vaccine

    10:41 a.m. Feb. 18, 2020

    - Jaimy Lee

  5. Health-Care Companies Try to Gauge the Costs of the Coronavirus.

    3:07 p.m. Feb. 7, 2020

    - Josh Nathan-Kazis

  6. Sanofi Had Lost Some Mojo, New CEO Says. Now It’s Playing to Win.

    4:31 p.m. Feb. 6, 2020

    - Josh Nathan-Kazis

  7. Zantac recall dents Sanofi's earnings

    7:57 a.m. Feb. 6, 2020

  8. Tapping the Brakes on Tesla

    8:00 p.m. Jan. 31, 2020

  9. Drugmakers Are Racing to Develop a Coronavirus Vaccine

    10:52 a.m. Jan. 31, 2020

    - Josh Nathan-Kazis

  10. Discover’s CEO Is Buying the Stock Dip

    7:30 a.m. Jan. 31, 2020

    - Ed Lin

  11. Big Merger Deals Are Missing at Health Conference. Here’s Why.

    11:13 a.m. Jan. 14, 2020

    - Josh Nathan-Kazis

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sny

Other News on SNY

  1. 17 Reasons Why I'm Confident Gilead's Remdesivir Will Work Against COVID-19

    12:18 p.m. Today

    - Seeking Alpha

  2. BioMarin (BMRN) Q4 Earnings Beat, Sales Miss, Valrox in Focus

    10:38 a.m. Today

    - Zacks.com

  3. Sanofi's Diversification Does Not Justify Its Valuation

    10:50 a.m. Feb. 26, 2020

    - Seeking Alpha

  4. Investing in Biotech Stocks the Right Way During an Epidemic

    11:27 a.m. Feb. 25, 2020

    - GuruFocus.com

  5. Sanofi Plans Spin-Off of API Unit Into a European Company

    10:28 a.m. Feb. 25, 2020

    - Zacks.com

  6. J&J, Sanofi, Inovio Hunt for Coronavirus Vaccines

    4:22 p.m. Feb. 24, 2020

    - Peter Loftus

  7. J&J, Sanofi, Inovio Hunt for Coronavirus Vaccines

    4:22 p.m. Feb. 24, 2020

    - Peter Loftus

  8. Sanofi creating pharma ingredient company to IPO

    11:12 a.m. Feb. 24, 2020

    - Seeking Alpha

  9. Bouncing Biotechs: A Multi-Company Review

    9:53 a.m. Feb. 24, 2020

    - Seeking Alpha

  10. FDA Clears New Type of Cholesterol Drug

    6:52 p.m. Feb. 21, 2020

    - Jared S. Hopkins

  11. FDA implements new rule aimed at boosting competition in insulin

    10:58 a.m. Feb. 20, 2020

    - Seeking Alpha

  12. Wall Street Breakfast: Spotlight On FOMC

    6:52 a.m. Feb. 19, 2020

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/sny

Press Releases on SNY

  1. A Steak War Sizzling in Animal Antibiotics Market, Latest Study Revealed

    7:12 a.m. Today

    - HTF Market Intelligence

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.